ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 41 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,319 | -16.2% | 5,651 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $14,693 | +116.7% | 5,651 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $6,781 | -26.4% | 5,651 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $9,211 | +31.6% | 5,651 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $7,000 | +16.7% | 5,651 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -33.3% | 5,651 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $9,000 | +12.5% | 5,651 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $8,000 | -33.3% | 5,651 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $12,000 | -25.0% | 5,651 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $16,000 | -27.3% | 5,651 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $22,000 | +69.2% | 5,651 | 0.0% | 0.01% | +40.0% |
| Q4 2020 | $13,000 | +30.0% | 5,651 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $10,000 | -9.1% | 5,651 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $11,000 | +37.5% | 5,651 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $8,000 | -70.4% | 5,651 | 0.0% | 0.00% | -63.6% |
| Q4 2019 | $27,000 | – | 5,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 25,000 | $41 | 0.05% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 183,783 | $299,566 | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 20,000 | $32,772 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 18,915 | $30,831 | 0.01% |
| Virtu Financial LLC | 24,953 | $41 | 0.01% |
| Long Focus Capital Management, LLC | 40,000 | $65,200 | 0.00% |
| Cedar Mountain Advisors, LLC | 5,651 | $9,211 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $19 | 0.00% |
| SITTNER & NELSON, LLC | 1,000 | $1,639 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,332 | $13,000 | 0.00% |